Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.
This report contains market size and forecasts of Crohn’s Disease Diagnostic and Therapeutic in Global, including the following market information:
Global Crohn’s Disease Diagnostic and Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Crohn’s Disease Diagnostic and Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Crohn’s Disease Diagnostic and Therapeutic include Abbvie, Celgene, Genetech, Johnson & Johnson, Pfizer, Prometheus Laboratories, Salix Pharmaceuticals and Takeda Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Crohn’s Disease Diagnostic and Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Crohn’s Disease Diagnostic and Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Crohn’s Disease Diagnostic and Therapeutic Market Segment Percentages, by Type, 2021 (%)
Diagnostics
Treatment
Global Crohn’s Disease Diagnostic and Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Crohn’s Disease Diagnostic and Therapeutic Market Segment Percentages, by Application, 2021 (%)
Hospital
Medical Research Institute
Other
Global Crohn’s Disease Diagnostic and Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Crohn’s Disease Diagnostic and Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Crohn’s Disease Diagnostic and Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Crohn’s Disease Diagnostic and Therapeutic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Celgene
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories
Salix Pharmaceuticals
Takeda Pharmaceutical